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Oral microbes are regarded as the principal cause of periodontitis. However, next-
generation sequencing studies have demonstrated that the transition from health to 
disease is attributed to a shift in the global balance of the microflora rather than to 
specific pathogens. This highlights the importance of examining each patient’s oral 
microbiome as prerequisite for assessing individual disease susceptibility and for the 
development of personalized therapies. The objective of this study is to observe the 
differences, if any, in the oral microbiome of individuals at different sites and to 
determine the site-specific factors that contribute to these differences. Site-specific 
subgingival plaque samples were collected at two time points five years apart from 303 
individuals in both healthy and periodontally diseased sites as part of the Study of Health 
in Pomerania (SHIP) effort. The same site was sampled at both timepoints. DNA was 
isolated from these samples and the V1-V3 and V4-V5 regions of the 16S rRNA gene 
was sequenced on the MiSeq platform. The sequences were aligned against the Human 
Oral Microbiome Database (HOMD) using BLAST to identify species present in each 
sample. Alpha and beta diversity metrics were computed to investigate the site-specific 
differences in health and disease. Linear Discriminant Analysis (LDA) was used to 
explore the influence of body mass index (BMI), diabetes, and smoking on the site-
specific differences of the diseased oral microbiome. The microbial profiles of two sites 
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within the same individual did not demonstrate significantly greater similarity than 
between two periodontally healthy individuals or two subjects with periodontitis (p>0.05, 
ANOSIM of Bray-Curtis Dissimilarity Index). LDA demonstrated that BMI, diabetes and 
smoking were significant drivers of this site-specific heterogeneity in diseased 
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Chapter 1. Introduction 
Background and Motivation 
Periodontology is a dental specialty concerned with the prevention and treatment of 
diseases affecting the tissues that anchor teeth to the maxilla and mandible. Periodontitis, 
one of these diseases, is estimated to affect almost 47% of adults in the United States1. 
When left untreated, this disease can lead to tooth loss, lower nutritional status, and 
problems with mastication and speech. The clinical community has come to a consensus 
that periodontitis does not affect every site in the mouth, and the progression and severity 
of the disease at affected sites is heterogeneous. One of the goals of periodontal treatment 
is to reduce the pathologically deepened subgingival sulcus to levels maintainable by 
home care. Consequently, periodontal therapies must be personalized to both the patient 
and each diseased site.  
The etiology of periodontitis has been studied extensively, but few studies have 
focused on the factors that determine the site-specific characteristics of the disease. 
Historically, research on the pathology of periodontitis has focused on immune-
inflammatory mediators and bacteria as the etiological agents. Most of these studies have 
utilized one of two approaches: aggregating data at the patient level or pooling samples 
from sites with disease. For example, most clinical studies report probing depths, 
attachment or plaque levels averaged for the whole mouth2. Similarly, studies on site-
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specific microbial profiles have used aggregations3-10. However, there are a few principal 
issues with this practice. Aggregations lead to a significant loss of power due to the 
relatively lower number of aggregated values available for data analysis. Additionally, 
utilizing such values leads to a loss of nuance in the data. For instance, a high plaque 
score on a few teeth and many teeth with moderate plaque scores will have the same 
average value. Lastly, aggregations assume that each site is an independent variable. 
However, each site is influenced by tooth-level and patient-level factors and behaviors11. 
There are issues with pooling samples as well. Recent research utilizing targeted DNA 
and proteomic methods have shown that pooled samples are not representative of the site-
specific nature of periodontitis12,13. In order to increase the precision of periodontal 
treatment, the treatment must be based on disease characteristics specific to each site 
rather than average disease characteristics of the whole mouth. 
 The influence of patient-level factors on oral microbiome stability is well-
documented. These factors, such as smoking, diabetes, and BMI, exert an environmental 
pressure on the oral microbiome. Moreover, all three are considered risk factors for 
periodontitis. Since periodontitis is associated with the dysbiosis of the oral microbiome, 
it is necessary to catalogue the effects of these environmental perturbations on the 
microbial ecosystem. Previous studies have found distinct ways that each of these 
perturbations effect the microbiome in both community structure and membership. 
Smoking creates a pathogen-rich, commensal-poor microbial ecosystem in periodontally 
healthy individuals that resembles ecosystems associated with periodontitis14,15. 
Hyperglycemia creates a microbial ecosystem that enforces habitat filtering, favoring 
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organisms that thrive under glucose-rich, pro-oxidant, protein-rich, and anaerobic 
conditions16. Lastly, multiple oral probiotic taxa are significantly associated with 
obesity17. 
 
Research Hypotheses and Objective  
Based on the review of literature, we hypothesized that subjects with periodontitis at both 
sites would display a unique oral microbial profile at each affected site, which would 
manifest as significant differences between the alpha and beta diversity of the sites. We 




Chapter 2. Methodology 
Subject Recruitment 
Subjects were recruited for this study as a part of the Study of Health in Pomerania 
(SHIP). From this effort, clinical periodontal data was available from 303 individuals at 
two time points five years apart18. Subjects also completed demographic and behavioral 
questionnaires, as well as medical and oral health history reports at both timepoints.  
 
Sample Collection 
Probing depth (PD), clinical attachment loss (CAL), and the presence of bleeding on 
probing (BOP) were measured at every tooth as part of the SHIP effort. PD is the 
distance from the gingival margin to the bottom of the periodontal pocket. CAL is a 
measure that quantifies the extent that the periodontal support surrounding a tooth has 
been destroyed. BOP measures whether or not the gingiva bleeds when probed. Site-
specific subgingival plaque samples were collected by inserting sterile endodontic paper-
points into the subgingival crevice at two sites with the deepest PD and separately stored. 
The same site was sampled at both timepoints.  
 
Subject Selection 
The periodontal data was used to classify each site in the mouth as periodontally healthy 
or diseased. This classification was based on PD, CAL and BOP of the site. A site with 
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PD of less than or equal to 3 mm, CAL less than 2mm and no BOP was classified as 
periodontally healthy. A site that did not meet these criteria was classified as diseased. 
Based on this, the 303 subjects were classified into a healthy group (subjects who were 
periodontally healthy at both sampled sites) and a disease group (subjects had periodontal 
disease at both sampled sites). Based on these criteria, we analyzed samples from 31 
healthy individuals and 52 individuals with periodontitis over two timepoints.  
 
Sequencing and Analysis Pipeline 
DNA was isolated using the MagMAXTM Total Nucleic Acid Isolation Kit from 1212 
site-specific samples. Subsequently, the V1-V3 and V4-V5 regions of the 16S rRNA 
gene were sequenced on the Illumina MiSeq platform for each sample. The primers used 
for sequencing were 5′- GTT TGA TCC TGG CTC AG- 3′ and 5′- GTA TTA CCG CGG 
CAG CTG GCA C-3′ for V1-V3, and   for V4-V5. Two primers were used because each 
primer can detect a range of genera that the other cannot. Used in combination, the 
primers recover a broader range of the microbiome than is possible with a single primer. 
However, some genera are detected by both primers. To prevent overcounting, the 
number of sequences assigned to an Operational Taxonomic Unit (OTU) by both primers 
was reduced by half. Primer averaging was completed as described previously19 using the 
implementation in the PhyloToAST software suite20. Cutadapt was used to find and 
remove adapter sequences, primers, and Poly-A tails from raw sequence data. As 
sequencing technologies produce reads closer to the 3’- and 5’- ends, the quality of reads 
decreases. Incorrect reads in these regions can have adverse effects on downstream 
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analyses. Sickle was used to determine at what base to trim the 3’- and 5’- ends via a 
sliding window with quality and length thresholds. Illumina MiSeq generates reads from 
both ends of DNA fragments. PEAR was used to merge these reads to create a sequence 
with greater overall read length. V4-V5 sequences were preprocessed through Cutadapt, 
Sickle, and PEAR; while, V1-V3 sequences were preprocessed solely through Cutadapt 
and PEAR. Next, split_libraries.py was used in QIIME to split sequence data based on 
barcodes that corresponded to each sample. Lastly, pick_OTUs.py in QIIME was used to 
assign OTUs to sequences from each sample. The blast method was used to cluster OTUs 
by aligning sequences against the Human Oral Microbiome Database (HOMD). Analyses 
were completed using PhyloToAST and QIIME20,21 pipelines.  
 
Statistical Analysis 
Principal coordinate analysis (PCoA) of Bray-Curtis dissimilarity indices was used to 
investigate the clustering based on site and Adonis test was used to determine statistical 
significance of beta diversity differences based on site22. Linear discriminant analysis 
(LDA) was performed using PhyloToAST20. LDA clustering for BMI, diabetes status, 
and smoking status groups were conducted to explore the level of site-specific difference 
within different groups of these factors. Tukey’s HSD and Dunn’s method for joint 
ranking were used to test the significance of intragroup and intergroup LDA clustering 
differences based on site in JMP. Alpha diversity of s-OTUs was quantified using 
Abundance Coverage Estimator (ACE) and Shannon Evenness Index (Shannon) in 
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PhyloToAST. Significance was evaluated using Wilcoxon Rank Sum test. Results were 
visualized using PhyloToAST19 as PCoA plots, kernel density plots, and LDA plots.  
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Chapter 3. Results 
Clinical and Demographic Characteristics of Groups 
Table 1 shows the demographic and clinical characteristics of the groups. A total of 
Table 1 Clinical and Demographic Features of Subjects 
2.7 million high quality, classifiable sequences from 166 samples were used for analysis.  
 
Site-specificity of the Oral Microbiome in Health 
In subjects that were periodontally healthy at both sites, principal coordinate analysis of 
Bray-Curtis dissimilarity indices did not show greater significant clustering of sites for 
V1-V3 or V4-V5 sequence regions (Adonis test, p = 0.75 & 0.18, respectively) within the 
same individual than between individuals (Figure 1, panels a-b). However, this difference 
could not be attributed to differences in alpha diversity (Figure 1c/e, p=0.24 & 0.16, Ace 
and Shannon indices computed on the V1-V3 region profiles respectively). The same 
lack of significance was observed for the Shannon diversity metric in the V4-V5 region 
sequences (Figure 1f, P=0.16). However, there was a significant difference in Ace 
between different sites within the same individual in the V4-V5 region (Figure 1d, 
P=0.01). Kernel density plots of the previous alpha diversity metrics can be seen in 
Age
Sex (% male)
Diabetes Status (% diabetic)
BMI (underweight: normal weight: overweight: obese)
Smoking Status (% smokers)
Mean PD (mm)
Abbreviation: BMI, body mass index; PD, probe depth.
Table 1 Clinical and Demographic Features of Subjects
35%
2.29 ± 0.644.79 ± 1.13
27%
0:9:23:20










Figures 1c-f. The peaks indicate the median values for each group, and the x-axis shows 




Figure 1 Alpha and Beta Diversity in Healthy Subjects 
(a-b) show the principal coordinate analysis (PCoA) of Bray-Curtis dissimilarity indices between two sites within the 
same individual in the V1-V3 and V4-V5 regions, respectively.(c-f) show the kernel density plots of alpha diversity 
(ace in a,b and Shannon in c,d) between two different sites in the same individual for the V1-V3 (a,c) and V4-V5 (b,d) 
sequences. The peak indicates the median values for each group and the x axis shows the data range. Only the ace 




Site-specificity of Oral Microbiome in Disease 
Similar to healthy subjects, in subjects with periodontitis at both sites, sites within the 
same individual did not exhibit greater similarity than those between subjects (P=0.87 & 
0.64, Bray-Curtis similarity Index of V1-V3 or V4-V5 sequence regions respectively, 
Figure 2a-b). However, as with healthy sites, this heterogeneity was not based on 
differences in alpha diversity (P=0.67 & 0.96, Ace and Shannon in the V1-V3 region 
sequences respectively, and P=0.24 & 0.73 V4-V5 region sequences). Kernel density 
plots of the previous alpha diversity metrics can be seen in Figures 2c-f. 
 
Drivers of Site-specificity of in Disease 
Linear discriminant analysis (LDA) revealed significant clustering of microbial profiles 
based on both BMI and periodontal health. Figures 3a-b show the LDA of BMI and 
periodontal health in diseased and healthy subjects, respectively. Figure 3b shows that 
healthy individuals contain sites that are microbially homogenous based on beta diversity 
as indicated by the lack of difference between groups of the same BMI at different sites 
except for the underweight group (P=0.03). Figure 3a shows an increased influence of 
BMI on the microbially profiles at each site, suggested by the significant difference 
between sites in the normal BMI individuals (P=0.02) and obese individuals (P=0.01). 
Also, significant clustering was observed based on smoking status between two sites 
within a single individual. Figure 3d does not show a significant clustering based on 
smoking status in periodontally healthy individuals. However, Figure 3c shows a 




Figure 2 Alpha and Beta Diversity in Disease Subjects 
(a-b) show the principal coordinate analysis (PCoA) of Bray-Curtis dissimilarity indices between two sites within the 
same individual in the V1-V3 and V4-V5 regions, respectively. Green lines demonstrate the distance between two sites 
in the same individual based on their microbial similarity. (c-f) show the kernel density plots of alpha diversity (ace in 
a,b and Shannon in c,d) between two different sites in the same individual for the V1-V3 (a,c) and V4-V5 (b,d) 




(P=0.0015). Lastly, significant clustering was observed based on diabetes status between 
two sites within the same individual who had periodontitis at two sites. Figure 3e shows a 
significant difference between the microbial profile of two sites in nondiabetics with 
periodontitis at both sites (P<0.0001).   
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Figure 3 Site-Specific Determinants in Disease  
Linear Discriminant Analysis (LDA) of species-level operational taxonomic units (s-OTUs) in periodontally healthy 
individuals who are smokers, nonsmokers, normal weight, underweight, overweight, and obese and individuals with 
periodontitis who are smokers, nonsmokers, normal weight, overweight, obese, diabetic, and nondiabetic. (a) 
Clustering of BMI groups in individuals with periodontitis. Significant intragroup difference based on site in normal 
(P=0.02) and obese (P=0.01) groups. (b) Clustering of BMI groups in healthy individuals. (c) Clustering of smoking 
status groups in individuals with periodontitis. Significant intragroup difference based on site in smoker (P=0.0015) 
group. (d) Clustering of smoking status groups in healthy individuals. (e) Clustering of diabetes status groups in 
individuals with periodontitis. Significant intragroup difference based on site in nondiabetic (P<0.0001) group.
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Chapter 4. Discussion 
 
Periodontitis is a site-specific disease, with the disease affecting many, but not all 
teeth in an individual with disease. Also, disease progression occurs through recurrent 
bursts of destruction followed by varying periods of quiescence at any given site. This 
temporally and spatially haphazard mode of disease progression has been named the 
random burst model, and therefore, the behavior of each site over time is the only 
measurable estimate of disease progression as well as therapeutic outcomes. In this study, 
we demonstrate that each site in the mouth harbors a unique microbiome, irrespective of 
whether the sites are healthy or have periodontitis. Our results corroborate previous studies 
in the literature that have examined the biogeography of the oral microbiome in health and 
dental caries23,24 and advance the field forward by demonstrating similar site-specific 
differences in periodontitis. Our data serves to explain the random burst model of disease 
progression. 
Previous studies have demonstrated that a gradient exists in the types of bacteria 
that colonize each tooth site, and that this gradient is based on the direction of salivary 
flow. We were unable to identify similar gradients in our study since we only sampled two 
sites per individual. Instead, we examined the effects of patient-level factors on site-
specific microbial heterogeneity, notably those factors that are known to increase 
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susceptibility to periodontitis. We discovered that BMI, smoking and hyperglycemia 
significantly influence the degree of dissimilarity between microbiota in each site within 
an individual. 
Importantly, we found that these differences between sites within the same mouth 
can be attributed to differing levels of the same species rather than differences in the 
types of species. 
The connection between patient-level risk factors and periodontitis have been 
studied extensively. Obesity is identified as a risk factor for periodontitis25. Also, 
obesity’s influence on the oral microbiome at the mouth-level has been investigated. A 
BMI greater than 30 is associated with a dysbiotic oral microbiome26. Since obese 
subjects appeared to have a different beta diversity compared to normal BMI subjects, it 
suggests that a large BMI is associated with a dysbiotic oral microbiome at the site-level 
as well. Also, the lack of influence of BMI on the beta diversity of healthy subjects 
compared to the distinct groups of beta diversity seen at each site based on BMI, suggest 
that BMI is contributing to differences in the microbiome among diseased sites. Previous 
studies have found that the dysbiotic shifts are correlated with subgingival adipokine 
levels and increased levels of pro-inflammatory cytokines in the gingival crevicular 
fluid25. Future work should determine how the influence of these cytokines and 
adipokines could lead to distinct microbiomes at different sites within the same 
individual. 
 Smoking’s influence on periodontitis risk is well-known as well. It is a risk factor 
for the initiation, extent, and severity of periodontitis27. The influence of smoking on the 
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oral microbiome at the mouth level has been studied as well. The subgingival 
environment in smokers is anaerobic, acidic, reducing, nutritionally deprived, and 
immune-impaired. This leads to a pathogen-rich, commensal-poor microbial ecosystem16. 
The differences in beta diversity among sites in subjects with periodontitis compared to 
healthy subjects’ sites suggests that the global changes seen in disease may also translate 
to the site-level. Also, the lack of site-specific differences in beta diversity seen based on 
smoking in healthy subjects suggests that smoking contributes to the site-specific 
differences in disease. Future work should determine how smoking could lead to 
disparate effects at different sites in the mouth.  
 Diabetes increases periodontitis risk. The underlying mechanism of this 
relationship involves immune functioning, neutrophil activity, and cytokine biology28. 
The effects of hyperglycemia on the oral microbiome have been investigated as well. The 
subgingival environment of a diabetic is glucose-rich, pro-oxidant, protein-rich, and 
anaerobic. The microbiome of diabetics is comprised of gram-positive facultatives and 
gram-negative anaerobes16. Site-specific differences were only observed for nondiabetic 
subjects with disease. This could be because the distinct subgingival environment in 
hyperglycemic individuals promotes a more homogeneous microbiome across sites. This 
finding disagrees with previous research that found that the dominant species in 
hyperglycemic individuals varied, which contributes to variation between individuals16.  
While there is a consensus that periodontitis is a site-specific disease, minimal 
research has focused on discerning the factors that determine the site-specific 
characteristics of the disease. This study sought to determine if diseased sites in each 
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individual are different microbially and determine the site-specific factors that contribute 
to these differences. Since the current understanding of periodontitis is influenced by 
studies that examined aggregated data from diseased sites, the identification of microbial 
differences between diseased sites, and the factors contributing to these differences, could 
transform future periodontal research and treatment. Moreover, the identification of site-
specific contributors to disease, such as obesity, hyperglycemia, and smoking status, 
enable early recognition and interventions for periodontitis, which could have a profound 
effect on the prevention and control of periodontitis and even, related systemic diseases 
such as Type-2 Diabetes Mellitus.  
In summary, this study highlights the need for the precision of periodontal 
treatment to be focused on the site-level rather than the patient level because the diseased 
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